BridgeMD
Compares treatment options for Ventricular Tachycardia
Official title Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
ClinicalTrials.gov ID: NCT05047198
What this study is testing
- What it's testing
- This study compares two arms - the current standard of care catheter ablation for Ventricular Tachycardia compared to stereotactic radiotherapy to non-invasively ablate ventricular tachycardia using a novel non-invasive ECG based body surface mapping technology. This allows investigators to identify ventricular tachycardia circuits to target for subsequent radio ablation.
- Phase 3: a large, late-stage study
- Time commitment: about 24 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Patient aged ≥55 years of age
- Cardiomyopathy (Left ventricular ejection fraction ≤ 35% and ICD in situ) AND
- Recurrent VT events despite previous CA OR
- VT events requiring intervention and PAINESD score ≥ 15
You likely can't join if
- Patients with NYHA Class IV heart failure \&/ or with LVAD in situ
- Patients not expected to live for more than one year for any reason
- Patients who have previously received thoracic radiotherapy
- Patients who are enrolled in another assigned by chance clinical trial
- Patients who are unable or unwilling to provide informed consent
- Patients aged ≤54 years of age
See the full eligibility criteria
- Patient aged ≥55 years of age
- Cardiomyopathy (Left ventricular ejection fraction ≤ 35% and ICD in situ) AND
- Recurrent VT events despite previous CA OR
- VT events requiring intervention and PAINESD score ≥ 15
- Patients with NYHA Class IV heart failure \&/ or with LVAD in situ
- Patients not expected to live for more than one year for any reason
- Patients who have previously received thoracic radiotherapy
- Patients who are enrolled in another assigned by chance clinical trial
- Patients who are unable or unwilling to provide informed consent
- Patients aged ≤54 years of age
- Pregnancy (all women of child bearing age and potential will have a negative β-HCG test before enrollment)
- Breastfeeding
- Women of childbearing age who refuse to use a highly effective and medically acceptable form of contraception (IUD, sterilization, birth control implant or birth control pill) throughout the study.
The study team makes the final eligibility decision.
Where it's taking place
- Ottawa, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ottawa, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.